![\"\"](\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/01\/Argano-ChipRegister-970.jpg\")
<\/p>\n <\/p>\n
Chip Register, CEO of Argano [Photo: Argano]<\/p>\n
Argano, a pioneering global consulting firm specializing in the design and delivery of high-performance business operations with an AI-forward approach to transformation, has acquired Pharosity Consulting, Inc.<\/p>\n
\u201cAs we move into 2026, Argano continues to build momentum through a disciplined acquisition strategy that is expanding both our scale and industry depth,\u201d Chip Register, Group CEO of Plano-based Argano, said in a statement. \u201cPharosity\u2019s distinct specialization and proven team complement our platform well, and we\u2019re excited to welcome them to Argano. This acquisition supports our continued focus on delivering AI-enabled high-performance operations for pharmaceutical organizations facing increasingly complex regulatory and data environments.\u201d<\/p>\n
Aggano had a busy 2025, moving into its new Plano headquarters<\/a>, complete with basketball court, and acquiring numerous companies. The Pharosity transaction is Argano\u2019s eighth deal since the launch of its transformational growth program in April 2025<\/a>, and the twenty-fourth since the company\u2019s founding in 2020.<\/p>\n Based in Doylestown, Pennsylvania, Pharosity specializes in Gross-to-Net government pricing, commercial contracting, and advanced analytics for pharmaceutical and biotech companies. Founded in 2015, Pharosity reinforces Argano\u2019s strategy to expand domain-specific capabilities and scale differentiated offerings. The acquisition boosts Argano\u2019s ability to help clients modernize finance, revenue, and analytics operations in highly regulated, data-intensive environments, the company said.<\/p>\n Pharosity provides a structured operating model designed to support complex regulatory and commercial functions with consistency and speed, Argano said. Its strong command of policy-driven processes and tailored delivery methods allow for more resilient revenue operations and scalable compliance programs. With mature methodologies and strong client relationships, Pharosity enhances Argano\u2019s position as a trusted partner for transformation in highly dynamic operating environments, while also providing a management methodology that complements and strengthens Argano\u2019s Strategic Business Consulting capabilities, the company said.<\/p>\n Support for complex regulatory and commercial demands<\/p>\n Pharosity\u2019s services are highly complementary to those of Twelve Consulting Group, which joined Argano in 2025, enhancing the firm\u2019s FP&A, ERP, and analytics solutions across the life sciences value chain. Together, they create a differentiated, end-to-end offering that combines strategic advisory, advanced analytics, and enterprise technology customized for pharmaceutical manufacturers facing evolving regulatory and commercial demands.<\/p>\n For pharmaceutical, medical device, and diagnostic companies, the expanded framework empowers the optimization of core operating models while supporting more comprehensive regulatory engagement and compliance, delivered through Argano\u2019s broader portfolio spanning business applications, AI, cloud infrastructure, data integration, and performance management, the company said.<\/p>\n \u201cJoining Argano enables us to extend our reach while continuing to deliver the focused expertise our clients value,\u201d said Brian Barbash, co-founder of Pharosity. \u201cWe\u2019re excited to scale within a platform that prioritizes precision, partnership, and sustainable outcomes, expanding what we can provide to our pharmaceutical clients as they navigate complexities and drive better results\u201d he said.<\/p>\n This transaction closed in December 2025. Bass, Berry & Simms served as legal advisor to Argano. Ernst & Young provided financial diligence advisory. KHSA and Wipfli served as financial advisors and Messerli Kramer as legal advisor to Pharosity.<\/p>\n Don\u2019t miss what\u2019s next. Subscribe\u00a0to\u00a0Dallas\u00a0Innovates.<\/p>\n Track Dallas-Fort Worth\u2019s business and innovation landscape with our curated news in your inbox Tuesday-Thursday.<\/p>\n \u00a0<\/p>\n \tR E A D\u00a0\u00a0 N E X T\t<\/p>\n \t Argano, a leading digital services consultancy, has acquired a total of 21 companies across the U.S. since 2020, from Salesforce consulting firms to digital supply chain advisories. Now it’s moved into a new Plano HQ with dynamic working spaces, two full-sized kitchens, a basketball court, and a recreational area with a pool table, ping pong table, and massage chair.<\/p>\n \t The North Texas-based precision oncology firm raised $494 million in its IPO. Founder David Halbert is now a newly minted biotech billionaire worth an estimated $3.3 billion, Forbes reports.<\/p>\n \t Bridging science and law, Westcott will drive MWM\u2019s Life Sciences Practice into the next frontier of biotech and MedTech innovation.<\/p>\n![\"\"](\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2025\/12\/Argano_Plano-videostill1-970-970x464.jpg\")
<\/a><\/p>\n![\"\"](\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2025\/10\/CarisLifeSciences_970-courtesy-970x464.jpg\")
<\/a><\/p>\n![\"Merritt](\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2025\/10\/Merritt-Westcott-high-res_970.jpg\")
<\/a><\/p>\n
![\"\"](\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/01\/CarisLifeSciences_2up_970.jpg\")
<\/a><\/p>\n![\"\"](\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2025\/10\/LifeScience_DeSoto-parcels-970.jpg\")
<\/a><\/p>\n